To investigate the molecular mechanism of gastric carcinogenesis, we a
nalyzed genetic instability and p53 gene mutations in 40 primary gastr
ic carcinomas. Tumor samples were from untreated patients with no fami
ly history suggestive of genetic predisposition to cancer. We screened
six microsatellite loci by the polymerase chain reaction (PCR) method
, and exons 5-8 of the p53 gene by the PCR-based denaturing gradient g
el electrophoresis and sequencing techniques. Microsatellite instabili
ty was detected in 32.5% (13/40), and gene mutations in 40% (16/40), o
f the tumors analyzed. No statistically significant associations were
found between genetic alterations and clinico-pathological variables (
with the exception of diffusion of lymph node metastases, which was in
versely associated with the presence of microsatellite alterations; P
< 0.01). Interestingly, a negative association was found between genet
ic instability and p53 gene mutations: 11 out of 13 tumors showing ins
tability proved to carry a nonmutated p53 gene versus 2/13 carrying a
mutated gene (P = 0.03). These observations suggest that genetic insta
bility and p53 gene mutations play a crucial role in the gastric carci
nogenic process, but likely act through distinct pathways during cance
r development. However, genetic instability is not in and of itself ne
oplastic. Therefore, we investigated whether insertion/deletion mutati
ons of the polyadenine tract within the transforming growth factor-bet
a type Il receptor gene (TGF-beta RII) were frequently present in gast
ric tumors with an RER+ (replication error) phenotype. We found RII mu
tations in 8/40 (20%) samples: mutations were present in 7/13 (54%) RE
R+ tumors versus 1/27 (4%) RER- cases (P < 0.001).